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Abstract
Background—Malignant cerebral edema (CED) complicates at least 20 % of large hemispheric 
infarcts (LHI) and may result in neurological deterioration or death. Midline shift (MLS) is a 
standard but crude measure of edema severity. We propose that volumetric analysis of shifts in 
cerebrospinal fluid (CSF) over time provides a reliable means of quantifying the spectrum of 
edema severity after LHI.
Methods—We identified 38 patients from 2008 to 2014 with NIHSS ≥8, baseline CT <6 h after 
stroke onset, at least 1 follow-up (FU) CT, and no parenchymal hematoma. The volumes of CSF 
(sulci, ventricles, and cisterns) ipsilateral (IL) and contralateral (CL) to infarct on baseline and FU 
CTs were quantified by manually assisted outlining with MIPAV image analysis software, as was 
infarct volume and MLS on FU CTs. Percentage change in CSF volumes (ΔCSF) from baseline to 
FU scans was correlated with MLS and compared in those with vs. without malignant edema 
(defined as hemicraniectomy, osmotic therapy, or death/neurological deterioration with MLS ≥5 
mm).
Results—11 of 38 subjects (29 %) developed malignant edema. Neither baseline NIHSS nor 
CSF volume differed between those with and without edema (median NIHSS 18 vs. 13, p = 0.12, 
CSF volume 102 vs. 124 ml, p = 0.16). Inter-rater reliability for CSF measurements was excellent 
(intraclass correlation coefficient 0.97). ΔCSF correlated strongly with MLS at peak edema (r = 
−0.75), even adjusting for infarct volume (p = 0.009). ΔCSF was also greater in those with 
malignant edema [−55 % (IQR −49 to −62) vs. −36 % (−27 to −45), p = 0.004]. ΔCSF was the 
greatest within IL sulci [−97 % (−86 to −99) vs. −71 % (−41 to −79), p = 0.002] but also 
significantly greater within CL sulci in those with malignant edema [−50 % (−29 to −65) vs. 
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−25 % (0 to −31), p = 0.014]. More than half this CSF volume reduction occurred by the time of 
first FU CT around 24 h after stroke, while MLS rose later.
Conclusions—Volumetric CSF analysis reliably quantifies CED and distinguishes those with 
malignant edema and MLS from those with a more benign course after LHI. ΔCSF may provide 
an earlier and more sensitive indicator of edema severity across a broader dynamic range than 
MLS.
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Introduction
Cerebral edema (CED) accounts for a large proportion of neurologic deterioration within the 
first week after large hemispheric infarction (LHI) and is the leading cause of early death 
[1]. Malignant edema develops in approximately 10–20 % of patients and can result in a 
rapid rise in compartmental pressure, subfalcine and uncal herniation, and clinical 
deterioration, often leading to death [2]. Mortality may be as high as 80 % despite medical 
management, unless surgical decompression is performed before herniation occurs [3]. 
Despite the importance of studying CED after LHI, little attention has been paid to 
understanding the kinetics of this process [4, 5]. No simple validated metric exists to easily 
and accurately quantify edema across the broad range of severities at several time points 
after stroke. Such a methodology would be important to characterize and thence understand 
the variability in trajectory of edema across patients while potentially providing a biomarker 
for studying and predicting outcomes after LHI, including early need for decompressive 
hemicraniectomy (DHC) [6].
Midline shift (MLS) and volume of infarct-related hypodensity are two commonly used 
surrogates of edema [7]. MLS is a crude estimate of subfalcine herniation which only 
becomes apparent later in the course and in severe cases, when edema has progressed 
beyond the point where reductions in intracranial blood and cerebrospinal (CSF) volume can 
compensate. It does not capture the full spectrum of edema severity, as those with milder 
degrees of edema may have little to no MLS, while others with temporal lobe infarction may 
develop uncal herniation despite minimal MLS. Hypodensity size is a variable combination 
of infarct and edema and so only approximates the actual edema-related increase in 
intracranial volume; it is also difficult to quantitate early when infarcts are subtle on 
computed tomography (CT) scans [8, 9]. In contrast, CSF is progressively displaced from 
the sulci and ventricles of the cerebral hemispheres as edema develops, and measures of CSF 
shifts may better capture the dynamic range and temporal course of CED after stroke.
We propose a CT-based volumetric analysis of shifts in CSF compartments as a novel 
method for more accurately quantifying CED after LHI. This leverages the widespread 
utilization of CT in acute stroke and the ease of CSF segmentation [10]. In this study, we 
aim to demonstrate the feasibility and reliability of CSF volumetrics in patients with LHI, 
and validate this novel metric against standard measures such as MLS and hypodensity 
volume. We will also evaluate whether changes in or ratios of specific CSF compartments 
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(such as ipsilateral (IL) or contralateral (CL) sulci or ventricles) better correlate with MLS 
and discriminate those who develop malignant edema compared to estimates of stroke 
severity or infarct-related hypodensity volume.
Methods
Patient Selection and Clinical Endpoint
We retrospectively identified patients with hemispheric infarction from acute ischemic 
stroke patients who were enrolled in a prospective stroke genetics study at our institution 
between 2008 and 2014. Inclusion criteria were (1) initial National Institutes of Health 
Stroke Scale (NIHSS) ≥8; (2) baseline head CT within 6 h of stroke symptom onset; and (3) 
at least 1 additional follow-up (FU) CT within 5 days of stroke (and at least 4 h from 
baseline CT) confirming hemispheric infarction [i.e., hypodensity in middle cerebral artery 
(MCA) ± PCA/ACA territories] as well as some degree of edema, defined as the presence of 
ventricular or sulcal effacement, MLS, and/or transtentorial herniation. FU CT scans were 
categorized based on timing as either “early edema” (within 48 h of stroke onset) or “peak 
edema” (2–5 days from onset, but prior to DHC). In those with several FU CTs, the CT 
closest to 24 h from onset was used as early edema CT and the FU CT with the most MLS 
was used as the peak edema CT. Subjects were excluded if FU CT demonstrated 
parenchymal hematoma (i.e., homogenous hyperdensity occupying <30 % [PH1] or >30 % 
of infarct zone [PH2], latter with significant mass effect or located beyond borders of the 
infarct) [11].
Clinical and demographic information was extracted from the prospective study database 
and supplemented with review of medical records. This included age, sex, race, time of 
stroke onset, tPA use, baseline and 24-h NIHSS, and GCS at baseline and at the time of each 
FU CT. Radiographic data extracted from baseline CT included the presence of hyperdense 
MCA (hd-MCA) sign and Alberta Stroke Program Early CT Score (ASPECTS) [12]. The 
primary clinical outcome of “malignant edema” was defined by the development of edema 
requiring hemicraniectomy or osmotic drug therapy, or CT exhibiting MLS C5 mm 
associated with death or decline in GCS (of two or more points) from baseline. In our single-
center institutional practice, osmotic therapy is only initiated at the time of neurologic 
worsening associated with edema on CT scan and is not used prophylactically. Similarly, 
DHC is performed in appropriate patients only after the development of edema and 
worsening mental status, but prior to signs of irreversible herniation.
Image Processing and Volumetric Analysis
Each CT scan was analyzed using the NIH Medical Imaging Processing, Analysis, and 
Visualization (MIPAV) software. Supratentorial CSF spaces [sulci and ventricles ipsilateral 
(IL) and contralateral (CL) to stroke, third ventricle] and basal cisterns were outlined on 
each slice using the semi-automated level-set tool (with manual outlining, if required, see 
Fig. 1). The volumes of each compartment and the total volume of CSF were then 
quantified. Total hemispheric volume (perimeter of brain from vertex down to the level of 
the anterior clinoid process) was also quantified. Hemispheric and sulcal symmetry was 
calculated as the ratio of IL vs. CL CSF volumes. The proportion of CSF in the cerebral 
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hemispheres was calculated as the ratio of total CSF volume to hemispheric volume. All FU 
scans also had measurement of MLS (displacement of the septum pellucidum) and infarct 
volume (by manual outlining of the visible hypodensity on each slice), and CED grading 
(grade 1 = focal brain swelling ≤1/3 of hemisphere, grade 2 = > 1/3 of hemisphere, grade 3 = 
edema with MLS) [13]. The absolute and percentage changes in volumes of CSF (total and 
each compartment) from baseline to early and peak edema FU CTs were calculated. ΔCSF 
was defined as the percentage change in total CSF volume from baseline to FU CT with 
peak edema in each subject. Continuous variables were reported as medians (with 
interquartile range, IQR) unless normality was confirmed by Shapiro-Wilk testing. Normally 
distributed variables were compared using t-tests, while non-parametric tests were employed 
for other comparisons of continuous variables.
Reliability of Measurements
The CSF regions of interest were independently outlined by two different raters (K.Y. and 
R.D.) in a subset of 13 CTs from five subjects and volumes of each obtained. Inter-rater 
reliability was calculated using the intraclass correlation coefficient (ICC) derived from a 
two-way mixed model of absolute agreement of these volumes between raters. This testing 
was repeated for the measurement of MLS on FU CT scans.
Validation of ΔCSF
Baseline and FU CSF volumes were compared using paired t-tests. Hemispheric and sulcal 
symmetry was tested by comparing the observed ratios to one (i.e., perfect symmetry) using 
t-tests at each time point. Validation of ΔCSF as a metric for quantifying CED after LHI was 
accomplished by (1) correlating ΔCSF with MLS and hypodensity volume at peak edema 
(using Pearson correlation coefficients). Partial correlations were then obtained for ΔCSF 
and MLS, adjusting for baseline NIHSS and peak hypodensity volume. (2) The association 
between ΔCSF and the endpoint of malignant edema was analyzed using the Mann–Whitney 
U test. If an increased risk of edema was associated with ΔCSF, then this association was 
further tested in binomial logistic regression, adding baseline clinical and radiographic 
covariates including age, baseline NIHSS, hd-MCA sign, ASPECTS, tPA use, and baseline 
CSF volume. ΔCSF was compared between CED grades using one-way ANOVA. Receiver 
operating characteristic (ROC) analysis was performed to identify optimal ΔCSF thresholds 
for malignant edema. To further evaluate the internal face validity of CSF measurements, we 
correlated baseline CSF volume (as a proportion of hemispheric volume) against patient age 
to determine if this accurately reflected brain atrophy.
Results
We identified 38 subjects with LHI from the prospectively enrolled cohort. Median baseline 
NIHSS was 15.5 (IQR 10–20) (Table 1). Baseline CT scan was performed at 74 min from 
stroke onset (IQR 36–166), and median ASPECTS score was 9 (IQR 8–10); 13 (34 %) had 
an hd-MCA sign and 82 % were treated with tPA. All had at least one FU CT for CSF 
volumetric analysis; 33 (87 %) had an early FU scan performed at a median of 18 h (IQR 
14–30), while 20 (53 %) had a scan at peak edema at a median of 67 h (52–88); 15 had both 
early and peak edema scans for serial analyses.
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Total baseline CSF volume was 120 ml (IQR 80–176 ml), of which just over two-thirds 
resided in the hemispheric sulci. The ratio of IL to CL hemispheric CSF volumes (i.e., 
hemispheric symmetry) was 0.96 ± 0.15 at baseline (p = 0.1 for comparison to 1). The ratio 
of IL:CL sulcal volumes (i.e., sulcal symmetry) was 0.94 ±0.16 (p = 0.048 for comparison to 
1). CSF volume represented 11 ± 5 % of hemispheric volume at baseline. The correlation 
between % CSF volume (as an estimate of brain atrophy) and subject's age was 0.77 (p < 
0.001, supplementary Fig.1). We did not find a correlation between ASPECTS score and 
baseline NIHSS or CSF volume/symmetry at baseline. However, hemispheric symmetry 
weakly correlated to baseline NIHSS (r = −0.36, p = 0.028). ICC for inter-rater measurement 
of CSF volumes was 0.92 for sulci and 0.99 for ventricles (both p < 0.001). Overall 
agreement for total CSF volumes was 0.97 (p < 0.001, supplementary Fig. 2). For 
comparison, ICC for the measurement of MLS was only 0.85.
Kinetics of Cerebral Edema
CSF volume fell 32 % from baseline to early FU scan (39 ± 24 ml, p < 0.001). The majority 
of this reduction occurred in IL sulci (22 ml or 56 %), but there was also a loss in CL sulci 
(12 ml/30 %) and IL ventricle (4 ml/ 28 %). Hemispheric symmetry fell to 0.63 ± 0.24 and 
sulcal symmetry to 0.57 ± 0.29 (both p < 0.001 compared to baseline). There was a further 
loss of CSF to scan with peak edema in those with both scans available: total CSF volume 
fell 55 ml compared to baseline (ΔCSF of 47 %) with IL sulci falling by 82 % (29 ml) and 
CL sulci by 35 % (14 ml). IL ventricular volume fell by 64 % (10 ml, all p < 0.001); there 
was no change in CL ventricular volume. Hemispheric symmetry fell to 0.31 ± 0.23 and 
sulcal symmetry to 0.21 ± 0.2 (both p < 0.001 in comparison to baseline and early CT). 
While over half the loss of CSF occurred by 24 h, the increase in MLS was seen 
predominantly on the peak edema scan (median of 5.3 mm, IQR 2.8–9.4) with little seen by 
24 h after stroke (median 2 mm, IQR 0–2.7 mm).
Validation of CSF Volumetrics with MLS and Malignant Edema
Malignant edema occurred in 11 subjects (29 %), with one additional subject having 5 mm 
or greater MLS without clinical deterioration. There was only a trend to higher baseline 
NIHSS in those with malignant edema, and hyperdense MCA sign was non-significantly 
more likely in those with edema (Table 1). There was no correlation between NIHSS and 
degree of MLS at peak edema (r = 0.13, p = 0.57). In contrast, we found a strong correlation 
between ΔCSF and MLS (r = −0.75, p < 0.001, Fig. 2). The volume of infarct-related 
hypodensity also correlated with MLS (r = 0.66, p = 0.001) and with ΔCSF (r = 0.54, p = 
0.01), but the association of ΔCSF and MLS remained even after adjusting for baseline 
NIHSS and peak infarct-related hypodensity volume (partial correlation of −0.63, p = 
0.005). MLS also inversely correlated with hemispheric (r = −0.64) and sulcal symmetry (r = 
−0.73, both p < 0.001). The CSF compartment most strongly correlated with MLS was % 
reduction in the volume of IL sulci (r = −0.76, p < 0.001).
There was a greater ΔCSF in those with malignant edema (55 vs. 35 % vs. baseline, p = 
0.004). Absolute volume reduction was not statistically different (53 vs. 39 ml, p = 0.2). 
Adjusting the association of ΔCSF with malignant edema for baseline covariates (age, 
NIHSS, hyperdense MCA, ASPECTS, baseline CSF volume) did not temper its association 
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(aOR 1.14, 95 % CI 1.02–1.28, p = 0.027). Reduction in IL and CL sulci volumes was also 
significantly greater in those with malignant edema (IL −92 vs. −65 %, p = 0.002; CL −43 
vs. −19 %, p = 0.014). There was significantly larger ΔCSF in those with CED grades 3 
(49 %) vs. 1 (14 %) or 2 (34 %, p = 0.005). ROC analysis revealed that ΔCSF had an area 
under curve of 0.85 (95 % CI 0.66–1.00, p = 0.006) with an optimal cutoff of 45 % 
providing 90 % sensitivity and 83 % specificity for malignant edema. For comparison, 
measurement of peak hypodensity volume provided 90 % sensitivity for volumes above 150 
ml but with only 58 % specificity.
Discussion
In this validation study, we have demonstrated that severity of CED after LHI can be 
quantified using a CT-based volumetric measure of CSF shifts over time. This novel measure 
utilizes serial brain imaging with CT scans as routinely performed in patients with LHI at 
risk for malignant edema. Outlining CSF compartments on baseline and FU scans provided 
a reliable and quantitative metric (with extremely high inter-rater agreement) that correlated 
strongly with infarct volume and MLS and was associated with the development of 
malignant edema independent of baseline markers of stroke severity and even infarct volume 
itself. In fact, we found that baseline NIHSS was only weakly associated with more severe 
edema in this cohort of stroke patients with hemispheric infarcts, and there was absolutely 
no correlation of baseline NIHSS with maximal severity of midline shift. This highlights the 
need for better early predictors of malignant edema.
CSF volumetric measures also exhibited good temporal resolution, demonstrating easily 
measurable differences at two distinct FU time points after LHI compared to baseline 
imaging. The reduction in CSF volume (ΔCSF) that we were able to quantify also paralleled 
the known time course of cerebral edema, with over half the shifts occurring by 24 h, 
providing a potential early radiographic predictor of malignant edema at a time point when 
accurate decisions about need for surgical interventions are critical. MRI measurement of 
infarct volume within 24 h has been demonstrated to predict malignant edema, but we 
believe that a CT-based approach would offer more generalizable advantages if it was able to 
aid in early decision making [4].
Using CSF volumetrics to quantify CED also possesses intrinsic biologic merit as it reflects 
the direct physiologic compensation that the brain undergoes in response to edema, as 
outlined over two centuries ago by anatomist Alexander Monro but expanded upon by 
Burrows and later Cushing who noted the importance of CSF in intracranial dynamics [14–
16]. Not only did we observe that the majority of hemispheric CSF resides in the bilateral 
sulci, but that the majority of CSF lost (i.e., compensation as edema develops, per the 
Monro-Kellie doctrine) comes from IL sulci. Measurement of % volume loss of IL sulci 
correlated most strongly with MLS and differentiated those with malignant edema from 
those less severely affected. Further exploring the compartmental dynamics of CSF might 
provide greater understanding of pressure shifts as edema develops. MLS is likely a later 
marker of edema when CSF compensation has been exhausted. Tracking early changes in 
CSF may allow elucidation of early kinetics not reflected simply by the measurement of 
MLS.
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Few studies have attempted to identify biomarkers of edema. One recent attempt utilized 
radiographic volume change in a roughly analogous way, but with MR imaging (at a time 
point of 62 h that was quite similar to our peak edema CT scans) and increase of brain 
volume rather than reduction in CSF volume as their target measurement [17]. However, this 
study included only 12 subjects, of whom only three developed neurologic deterioration 
from edema. Nonetheless, it is interesting that they found that brain volume increased by 72 
ml, a value not dissimilar to the 55-ml loss of CSF we measured. They found a trend to 
greater increase in volume in those with edema but no correlation of their measure with 
MLS. We believe that CSF volumetric measurements may provide a more sensitive marker 
of edema that detects subtle changes in sulcal effacement and compression of ventricles. 
Furthermore, performing MR scans in patients with large strokes who are often ventilated or 
unstable may be challenging, while CT scans are rapid and easier to obtain in this 
population; they are also more likely to be performed serially, which may facilitate the study 
of edema kinetics.
We found a 14-ml greater loss in CSF volume in those with malignant edema. While this 
may appear a minor difference, it is clear that small changes in intracranial volume can be 
quite clinically significant. A volumetric MR-based study of the effect of mannitol found an 
8-ml reduction in brain volume after a bolus dose in LHI patients with MLS [18]. Despite 
this modest effect, it is apparent that osmotic agents like mannitol and hypertonic saline can 
reverse transtentorial herniation by reducing brain volume [19].
We also found a significant correlation between baseline CSF volume and age, further 
supporting the face validity of our measurements. While greater atrophy was not associated 
with lower risk of malignant edema in this study, having more CSF and room to compensate 
for edema may be significant and should be explored in future larger studies. One prior 
study did analyze total CSF volume at baseline (but not change over time) in relation to 
malignant edema after proximal occlusion [20]. They found that this intracranial volume 
reserve was lower in those developing malignant edema, while NIHSS was no different. In 
that study, only total (and not compartmental) CSF volume was measured and even then it 
was only estimated using a simple thresholding approach. While this method seemed 
feasible for baseline imaging, it cannot accurately delineate CSF in the presence of infarct-
related hypodensity (with overlapping low density adjacent to sulci and ventricles) on FU 
CT scans. We applied a semi-automated CSF outlining approach with human input that is 
likely much more accurate in that setting. The next step in expanding the applicability of our 
approach to a broad spectrum of stroke patients is developing a fully automated algorithm 
that can outline CSF on serial CT scans. Not only could this be useful for understanding 
edema kinetics and prediction of malignant trajectories at early time points, but also be 
applied to large-scale genomic evaluations of edema after stroke, an endeavor that could 
uncover biologic targets to prevent edema formation [21–23].
There are several limitations to note in this preliminary analysis. While stroke patients were 
prospectively enrolled in this cohort, selection and image analysis was retrospectively 
performed and with some knowledge of radiographic outcomes (i.e., MLS) and clinical 
endpoints (i.e., need for hemicraniectomy), which could introduce a degree of bias. We also 
utilized a convenience sample of available scans that were generally performed at times of 
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neurologic deterioration and so hopefully represent a close approximation of ‘peak edema,’ 
but were not standardized in timing. Larger prospective studies should validate the 
generalizable accuracy of CSF volumetrics to predict edema (adjusting for stroke severity 
and other important covariates) while employing automated techniques to negate any such 
biases. We also plan to further evaluate the utility of CSF changes at 24 h as a standardized 
early biomarker of edema severity.
Conclusions
CSF volumetrics offers a reliable and quantifiable measure of CED after LHI that better 
captures the full range of edema severity than MLS and does not simply recapitulate 
measuring infarct-hypodensity volume. We confirmed that those with more MLS and 
malignant edema manifest larger ΔCSF, validating our novel metric. We propose that this 
CT-based quantitative metric of edema will allow widespread study of early changes to 
predict malignant edema and further analyses of the early versus delayed kinetics of edema 
after LHI.
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Fig. 1. CSF spaces outlined on CT scan slice at baseline and peak edema in sample patient
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Fig. 2. Correlation of peak midline shift with total ΔCSF (top) and in ipsilateral and contralateral 
sulci (bottom, left, and right)
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Table 1
Clinical and radiographic characteristics in all subjects, categorized by development of 
malignant cerebral edema
Variable All subjects Malignant edema (n = 11) No malignant edema (n = 27) p value
Age (years) 62 ± 16 57 ± 17 64 ± 16 0.21
Gender, female 19 (50 %) 7 (64 %) 12 (44 %) 0.48
Race, AA (%) 8 (21 %) 2 (18 %) 6 (22 %) 1.00
Baseline NIHSS 15.5 (10–20) 18 (14–21) 13 (10–20) 0.12
ASPECTS 9 (8–10) 9 (8–10) 10 (9–10) 0.18
Hd-MCA sign 13 (34 %) 6 (55 %) 7 (26 %) 0.09
tPA treatment 31 (82 %) 9 (82 %) 22 (82 %) 1.00
24-h NIHSS 17 (13–22) 20 (17–25) 16 (10–21) 0.04
Hypodensity volume 201 (96–280) 282 (227–329) 135 (70–203) 0.001
Peak MLS 4.9 ± 3.7 8.5 ± 2.6 2.5 ± 2.0 <0.001
Mortality 5 (13 %) 1 (9 %) 4 (15 %) 1.00
Values are reported as mean ± standard deviation, median (interquartile range), or proportions
AA African-American, Hd-MCA hyperdense MCA, MLS midline shift
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